We and others have reported previously that the phosphorylation of STAT3 is a common hallmark of DLBCL patients with unfavorable outcome (Ding et al, 2008; Meier et al, 2009; Ok et al, 2014). Here, STAT3 is linked to diffuse large B-cell lymphoma.